Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Wollongong
Clinical trial register · Australia

Clinical Trials in Wollongong, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3343 matching records held by the registry are in this view. Synced 15 Oct 2026, 03:18 UTC
3343
Studies in scope
all four open statuses
1804
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1096 Adelaide 565 Sydney 508 Westmead 416 Clayton 407
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca14 Sanofi7 Janssen Research & Development, LLC6 AbbVie5 Regeneron Pharmaceuticals4
Site location
Melbourne1096 Adelaide565 Sydney508 Westmead416 Clayton407
All 401 locations
Target enrolment
to

Trials with a site in Wollongong

148 of 3343 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Not yet open
Boehringer Ingelheim
Phase 3
270
Campbelltown, Wollongong, Ivanhoe, Nedlands
2026-12-14
Not yet open
AbbVie
Phase 3
520
Wollongong, Benowa, South Brisbane, Melbourne, Richmond, Murdoch, Nedlands
2026-11-30
Not yet open
Novo Nordisk A/S
Phase 3
8,500
Canberra, Camperdown, Wollongong, Chermside, Douglas, Milton, Rockhampton, Sippy Downs
2026-10-26
Recruiting
ML-016 in Advanced Cancer With Lung and/or Liver Involvement
NCT07723482Advanced Solid Tumor With Lung and/or Liver Involvement
BrYet US, Inc.
Phase 1/2
108
Miranda, Wollongong, Buderim
2026-09-25
Not yet open
VelaVigo Bio Inc
Phase 1/2
260
Randwick, Wollongong, Frankston
2026-08-24
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
DrugElecoglipron
AstraZeneca
Phase 3
6,950
Blacktown, Campbelltown, Frankston, Hoppers Crossing, North Tamworth, Rockhampton, Wollongong
2026-08-24
Recruiting
AstraZeneca
Phase 3
7,000
Castle Hill, Fitzroy, Gosford, Melbourne, Perth, Southport, St Leonards, Wollongong
2026-08-21
Not yet open
LaNova Medicines Limited
Phase 1/2
90
North Ryde, Wollongong, Brisbane
2026-07-15
Recruiting
Janssen Research & Development, LLC
Phase 2
230
Concord, Wollongong
2026-06-30
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
NCT07652658Idiopathic Pulmonary Fibrosis (IPF)
AstraZeneca
Phase 2
359
Camperdown, Port Macquarie, Wollongong
2026-06-11
Recruiting
FibroBiologics
Phase 1/2
120
Coffs Harbour, New Lambton Heights, Saint Leonards, Wollongong, South Brisbane, West Mackay, Clayton, Melbourne
2026-06-01
Recruiting
Kivu Bioscience Inc.
Phase 1
76
Sydney, Wollongong, Brisbane
2026-05-25
Recruiting
BeOne Medicines
Phase 3
1,056
Blacktown, Liverpool, Wollongong, Birtinya, Douglas, Melbourne, Murdoch, Nedlands
2026-05-22
Active, closed
Contralateral Claims Study of Clareon Vivity Pro
NCT07484191Aphakia, Presbyopia
Alcon Research
Not applicable
165
Campsie, Sydney, Wollongong, Woolloongabba, East Melbourne, Mornington
2026-04-28
Active, closed
Kailera
Phase 2
306
Dee Why, Miranda, Wollongong, Norwood, Altona N.
2026-04-06
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
150
Randwick, Wollongong, Adelaide, Fitzroy, Melbourne
2026-03-26
Recruiting
Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC
NCT07197580ccRCC, Renal Cell Carcinoma (Kidney Cancer), Renal Cell Carcinoma (RCC), Renal Cell Cancer Metastatic
Telix Pharmaceuticals (Innovations) Pty Limited
Phase 3
40
Sydney, Wollongong, Heidelberg, Melbourne N., Murdoch
2026-03-25
Recruiting
A Study of Terbium 161 (161Tb)-RAD402 in Participants With CRPC
NCT07259213Castration-resistant Prostate Cancer
Radiopharm Theranostics, Ltd
Phase 1/2
73
Wollongong, Nedlands
2026-03-05
Recruiting
Incyte Corporation
Phase 3
700
Port Macquarie, Randwick, Waratah, Westmead, Wollongong, Southport, Townsville, Woolloongabba
2026-03-05
Recruiting
Novartis Pharmaceuticals
Phase 1/2
181
Camperdown, Wollongong
2026-01-13
Active, closed
Kailera
Phase 3
1,270
Bruce, Blacktown, Charlestown, Kanwal, Leichhardt, Penrith, Sydney, Wollongong
2026-01-12
Active, closed
Kailera
Phase 3
2,530
Charlestown, Sydney, Wollongong, Sippy Downs, Norwood, Heidelberg Heights, Melbourne
2025-12-18
Recruiting
Incyte Corporation
Phase 3
466
Camperdown, Concors, Wollongong, South Brisbane, Townsville, Box Hill
2025-12-09
Recruiting
Alexion Pharmaceuticals, Inc.
Phase 2
75
Clayton, Heidelberg, Nedlands, Wollongong
2025-11-26
Recruiting
AstraZeneca
Phase 3
400
Gosford, Kogarah, South Brisbane, St Albans, Wollongong
2025-10-31
Recruiting
PRIORITY-CONNECT 2 Trial
NCT06976710Colorectal Cancer, Colorectal Neoplasms
Surgical Outcomes Research Centre (SOuRCe)
Not applicable
564
Coffs Harbour, Newcastle, Sydney, Wagga Wagga, Wollongong, Brisbane, Adelaide, Ballarat
2025-10-15
Recruiting
Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
NCT06989359IgAN, C3G, Complement-mediated Kidney Disease, IgA Nephropathy (IgAN)
ADARx Pharmaceuticals, Inc.
Phase 2
45
Liverpool, Wollongong, Sydney, Woolloongabba
2025-08-28
Recruiting
LaNova Medicines Limited
Phase 1/2
80
Wollongong, Adelaide, Frankston
2025-08-28
Recruiting
Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.
Phase 2
200
Brookvale, Miranda, North Altona, Norwood, Wollongong
2025-08-25
Recruiting
Amgen
Phase 3
11,000
Garran, Camperdown, Charlestown, Concord, Merewether, Orange, Wollongong, Auchenflower
2025-08-22
Recruiting
The George Institute
Phase 2
524
New Lambton Heights, Penrith, Randwick, St Leonards, Westmead, Wollongong, Brisbane, Gold Coast
2025-08-13
Active, closed
Novo Nordisk A/S
Phase 3
877
Macquarie Park, Wollongong, Townsville, Oaklands Park, Fitzroy, Heidelberg Heights, Parkville
2025-08-11
Recruiting
AbbVie
Phase 1
135
Blacktown, Wollongong, Melbourne, Nedlands
2025-08-07
Active, closed
Windward Bio
Phase 2
136
Brookvale, Coffs Harbour, Maroubra, Miranda, Wollongong, Birtinya, North Altona
2025-07-24
Recruiting
Vir Biotechnology, Inc.
Phase 1
450
Wollongong, Woolloongabba
2025-07-22
Recruiting
Merck Sharp & Dohme LLC
Phase 3
477
Wollongong, Birtinya, Clayton, St Albans
2025-07-16
Recruiting
Optimal Implementation of Antimicrobial Stewardship in General Practice
NCT06953804The Use of Antimicrobial Stewardship in in General Practice (Family Medicine), Respiratory Tract Infections (RTI)
University of Wollongong
Not applicable
120
Wollongong, Gold Coast, Hobart, Melbourne
2025-07-01
Recruiting
Marea Therapeutics
Phase 2
316
Canberra, Kanwal, Merewether, Miranda, Wollongong, Herston, Milton, Leabrook
2025-06-30
Recruiting
AstraZeneca
Phase 2
987
Cairns, Nedlands, Norwood, Osborne Park, South Brisbane, Wollongong
2025-06-27
Recruiting
XII Medical
Not applicable
30
Canberra, Sydney, Wollongong, Brisbane, Perth
2025-06-24
Active, closed
Atridia Pty Ltd.
Phase 1
25
Sydney, Adelaide, Brisbane, Melbourne, Perth, Wollongong
2025-06-15
Recruiting
BioNTech SE
Phase 3
480
Adelaide, Clayton, Gosford, Melbourne, Nowra, Saint Albans, South Brisbane, Wollongong
2025-06-10
Active, closed
Paradigm Biopharmaceuticals Ltd.
Phase 3
466
Brookvale, Charlestown, Miranda, Wollongong, South Brisbane, Southport, Adelaide, Stepney
2025-05-29
Recruiting
Eikon Therapeutics
Phase 2/3
740
Wollongong, Chermside, Bedford Park, Box Hill, Frankston
2025-05-22
Recruiting
LaNova Medicines Limited
Phase 1/2
87
Ryde, Wollongong, Perth
2025-05-06
Recruiting
Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.
NCT06855745Atopic Dermatitis (Eczema), Atopic Dermatitis Eczema, Atopic Dermatitis, Atopic Dermatitis (AD)
DrugZabalafin
Alphyn Biologics
Phase 2
72
Brookvale, Darlinghurst, Kogarah, Kotara, Waitara, Wollongong, Benowa, Wellers Hill
2025-03-25
Recruiting
AstraZeneca
Phase 3
990
Coffs Harbour, Frankston, Garran, Nedlands, New Lambton, Spearwood, Wollongong, Woodville South
2025-03-25
Active, closed
Immutep S.A.S.
Phase 3
756
Elizabeth Vale, Greenslopes, Melbourne, Southport, Subiaco, Tiwi, Waratah, Wollongong
2025-03-21
Active, closed
Amgen
Phase 3
3,853
Botany, Charlestown, Miranda, St Leonards, Wollongong, Meadowbrook, Norwood, Oaklands Park
2025-03-12
Recruiting
AstraZeneca
Phase 2
80
East Melbourne, Wollongong, Woodville South
2025-03-12
Recruiting
GlaxoSmithKline
Phase 1/2
305
Liverpool, Wollongong
2025-03-04
Recruiting
Daiichi Sankyo
Phase 3
726
Bedford Park, Clayton, Douglas, North Melbourne, St Leonards, Subiaco, Wollongong
2025-02-27
Recruiting
A Study of DM002 in Patients With Advanced Solid Tumors
NCT06751329Ovarian Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms, Colorectal Neoplasms
Xadcera Biopharmaceutical (Suzhou) Co., Ltd.
Phase 1/2
280
Randwick, Wollongong, Adelaide
2025-02-17
Recruiting
HEAT Trial (HER2 Antibody Therapy With Lutetium-177)
NCT06824155HER2 Gene Mutation, Advanced Solid Tumors
Radiopharm Theranostics, Ltd
Early Phase 1
30
Kingswood, Macquarie Park, Wollongong, Fitzroy, Murdoch
2025-02-12
Recruiting
Rivermark Medical
Not applicable
215
Wollongong
2025-02-10
Recruiting
BioNTech SE
Phase 3
621
Waratah, Wollongong, Cairns, Kurralta Park, Woodville, Frankston, Heidelberg, St Albans
2025-02-03
Recruiting
Fortvita Biologics (USA)Inc.
Phase 1
250
Wollongong, Adelaide
2025-01-10
Recruiting
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
190
Westmead, Wollongong, Heidelberg
2024-12-30
Active, closed
Arcus Biosciences, Inc.
Phase 3
610
Camperdown, Clayton, Murdoch, Wollongong
2024-12-13
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
186
Sydney, Wollongong, Benowa, Adelaide, Melbourne
2024-12-11
Recruiting
Janssen Research & Development, LLC
Phase 1
276
Clayton, Fitzroy, Melbourne, Waratah, Wollongong
2024-12-04
Recruiting
AstraZeneca
Phase 3
1,160
Darlinghurst, Hyde Park, Southport, Wollongong
2024-11-27
Recruiting
AstraZeneca
Phase 3
1,160
Darlinghurst, Hyde Park, Southport, Wollongong
2024-11-18
Recruiting
Sanofi
Phase 1
87
Wollongong, Melbourne
2024-10-30
Recruiting
Shanghai Allink Biotherapeutics Co., Ltd.
Phase 1/2
202
Wollongong, Birtinya, South Brisbane, Macquarie
2024-10-24
Recruiting
Australasian Gastro-Intestinal Trials Group
Phase 2
78
Sydney, Wollongong, Brisbane, Cairns, Toowoomba, Adelaide, Melbourne, Kalgoorlie-Boulder
2024-10-14
Recruiting
Xencor, Inc.
Phase 1/2
270
Adelaide, Joondalup, Melbourne, Nedlands, South Brisbane, Southport, Wollongong
2024-10-10
Recruiting
Australasian Gastro-Intestinal Trials Group
Phase 2
40
Camperdown, Clayton, St Leonards, Westmead, Wollongong, Woolloongabba, Bedford Park, Melbourne
2024-09-23
Active, closed
Tectonic Therapeutic
Phase 2
191
Camperdown, Macquarie, New Lambton, Sydney, Wollongong, Chermside, Hobart, Malvern
2024-09-04
Active, closed
Phase IIa Study Evaluating AZD7798 in Crohn's Disease
NCT06450197Moderate to Severe Crohn's Disease
DrugAZD7798
AstraZeneca
Phase 2
120
Adelaide, Box Hill, Fitzroy, Melbourne, Wollongong
2024-08-28
Active, closed
Genmab
Phase 3
379
Garran, Sydney, Wollongong, Toowoomba, Clayton, Perth
2024-08-13
Recruiting
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1/2
116
Wollongong, Heidelberg, Melbourne
2024-07-29
Recruiting
Telix Pharmaceuticals (Innovations) Pty Limited
Phase 3
520
Sydney, Wollongong, Melbourne, Perth, Brisbane, East Maitland, Heidelberg, Malvern
2024-07-26
Active, closed
Novo Nordisk A/S
Phase 3
10,000
Concord, Kingswood, Liverpool, Randwick, Wollongong, Birtinya, Brisbane, Cairns
2024-06-25
Active, closed
Dynavax Technologies Corporation
Phase 1/2
764
Blacktown, Botany, Brookvale, Kanwal, Miranda, Waitara, Wollongong, Herston
2024-06-17
Active, closed
Amgen
Phase 3
563
Camperdown, Wollongong, Greenslopes, Adelaide, Clayton, Nedlands
2024-06-05
Recruiting
177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors
NCT06305962PDL1 Gene Mutation, Non Small Cell Lung Cancer, Small Cell Lung Cancer ( SCLC ), TNBC, Triple Negative Breast Cancer
Radiopharm Theranostics, Ltd
Early Phase 1
30
Kingswood, Wollongong, Southport, Adelaide, Murdoch
2024-06-03
Recruiting
BeOne Medicines
Phase 1
308
Blacktown, North Ryde, Wollongong, Woolloongabba, Clayton, Malvern, Melbourne, Nedlands
2024-04-12
Active, closed
Novo Nordisk A/S
Phase 3
673
Garran, New Lambton Heights, Wollongong, Brisbane, Chermside, Ballarat, Epping, Mulgrave
2024-04-01
Active, closed
AstraZeneca
Phase 3
2,554
Birtinya, Clayton, Darlinghurst, Gosford, Kogarah, Perth, St Leonards, Wollongong
2024-03-29
Active, closed
Janssen Research & Development, LLC
Phase 3
838
Adelaide, Box Hill, Darlinghurst, Fitzroy, Southport, West Perth, Wollongong
2024-01-22
Recruiting
AstraZeneca
Phase 1/2
226
Fitzroy, Melbourne, Nedlands, Wollongong
2023-12-05
Recruiting
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
NCT06022029Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Lymphoma, Non-Hodgkin
DrugCemiplimab
OncoNano Medicine, Inc.
Phase 1
168
Darlinghurst, Wollongong, Buderim, Southport, Woolloongabba, Bedford Park, Subiaco
2023-10-13
Recruiting
Study of AVZO-021 in Patients With Advanced Solid Tumors
NCT05867251Advanced Solid Tumor, HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast Cancer, CCNE1 Amplification
DrugsAVZO-021·Sacituzumab Govitecan·Abemaciclib·Ribociclib
Avenzo Therapeutics, Inc.
Phase 1/2
430
Macquarie University, Wollongong
2023-08-30
Active, closed
Regeneron Pharmaceuticals
Phase 2/3
160
Macquarie Park, Wollongong, Ballarat, Bendigo, Fitzroy, Murdoch
2023-08-08
Recruiting
Lin BioScience, Inc
Phase 1/2
90
Wollongong, Benowa, Adelaide, Melbourne, Nedlands, Perth
2023-07-20
Active, closed
Regeneron Pharmaceuticals
Phase 2/3
149
Macquarie Park, Wagga Wagga, Wollongong, Ballarat, Bendigo
2023-06-30
Active, closed
Grey Wolf Therapeutics
Phase 1/2
300
Bedford Park, Blacktown, Darlinghurst, Heidelberg, Melbourne, South Brisbane, Wollongong
2023-05-21
Recruiting
Platform of Randomized Adaptive Clinical Trials in Critical Illness
NCT05440851Respiratory Insufficiency, Extracorporeal Membrane Oxygenation Complication, Mechanical Ventilation Pressure High
University Health Network, Toronto
Not applicable
6,250
Camperdown, Kingswood, Wollongong, Bedford Park, Darlinghurst, Bendigo, Frankston, Geelong
2023-04-30
Recruiting
AUM Biosciences Pte Ltd
Phase 2
120
Camperdown, Wollongong, Benowa, Malvern, Wendouree
2023-04-14
By invitation
Sanofi
Phase 2
70
Blacktown, Saint Leonards, Wollongong, Melbourne, Richmond
2023-04-05
Active, closed
Sanofi
Phase 2
118
Wollongong, Melbourne
2023-04-05
Active, closed
Daiichi Sankyo
Phase 3
1,170
Adelaide, Bedford Park, Frankston, Kogarah, Wollongong, Woolloongabba
2023-01-11
Active, closed
Amgen
Phase 3
7,297
Garran, Camperdown, Concord, Liverpool, Sydney, Wollongong, Auchenflower, Bundaberg
2022-12-14
Active, closed
University Medical Center Groningen
Phase 3
1,750
Canberra, New Lambton Heights, Sydney, Wollongong, Birtinya, Brisbane, Douglas, Adelaide
2022-11-08
Recruiting
Canadian Cancer Trials Group
Phase 2
84
Concord, Nowra, Wollongong, Adelaide, Heidelberg, Perth
2022-11-01
Recruiting
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
470
Darlinghurst, Wollongong, Benowa, Birtinya
2022-10-26
Recruiting
Janssen Research & Development, LLC
Phase 3
1,590
Camperdown, Geelong, Liverpool, Nedlands, New South Wales, Wollongong, Woolloongabba
2022-10-25
Recruiting
Celgene
Phase 3
810
Liverpool, Waratah, Wollongong, Birtinya, Box Hill, Melbourne, Nedlands
2022-09-20
Active, closed
AstraZeneca
Phase 3
594
Elizabeth Vale, Lismore, Murdoch, South Brisbane, Wollongong
2022-09-15
Recruiting
Guideline Oriented Approach To Lipid Lowering In Asia-Pacific
NCT05325034Cardiovascular Diseases, Acute Coronary Syndrome, Atherosclerosis, Hypercholesterolemia
Stephen Nicholls
Not applicable
2,000
Wollongong, Cairns, Bedford Park, Clayton, Melbourne
2022-09-15
Recruiting
ModernaTX, Inc.
Phase 1/2
361
Miranda, Wollongong, Wollstonecraft, Melbourne, Nedlands
2022-09-01
Active, closed
Sanofi
Phase 3
531
Liverpool, Waratah, Wollongong, Adelaide, Melbourne, Richmond
2022-06-23
Active, closed
Australasian Gastro-Intestinal Trials Group
Phase 2
20
Sydney, Wollongong, Melbourne
2022-05-20
Active, closed
IO Biotech
Phase 3
407
Albury, Westmead, Wollongong, Cairns, Bedford Park, Woodville South, Birtinya, Melbourne
2022-05-17
Active, closed
Pfizer
Phase 3
854
Camperdown, Nowra, Westmead, Wollongong, Benowa, Clayfield, Woolloongabba, East Melbourne
2022-03-25
Recruiting
University of Sydney
Phase 3
445
Bankstown, Camperdown, Concord, Frenchs Forest, Liverpool, New Lambton Heights, Randwick, Wollongong
2021-10-14
Active, closed
Janssen Research & Development, LLC
Phase 1
166
Fitzroy, Melbourne, Southport, Wollongong
2021-09-22
Recruiting
Australian and New Zealand Intensive Care Research Centre
Phase 2
450
Sydney, Wollongong, Birtinya, Brisbane, Southport, Adelaide, Geelong, Melbourne
2021-07-15
Active, closed
Pfizer
Phase 3
599
Camperdown, Wollongong, Brisbane, Southport, Woodville South, East Melbourne, Malvern, Richmond
2021-05-12
Active, closed
Incyte Corporation
Phase 3
654
Kogarah, Sydney, Wollongong, Southport, Adelaide, Bedford Park, Melbourne, St Albans
2021-04-15
Active, closed
Bristol-Myers Squibb
Phase 1/2
216
Blacktown, Wollongong, East Melbourne, Heidelberg, Nedlands, West Perth
2021-03-22
Active, closed
Mirati Therapeutics Inc.
Phase 3
453
Mackay, Bedford Park, Clayton, Douglas, St Leonards, Tweed Heads, Wollongong, Woolloongabba
2021-02-23
Active, closed
AbbVie
Phase 1
81
Wollongong, Heidelberg
2021-02-23
Recruiting
Sanofi
Phase 1/2
258
Wollongong, Melbourne, Richmond
2021-01-25
Active, closed
BioNTech SE
Phase 2/3
358
Adelaide, Bedford Park, Fitzroy, Saint Leonards, Tugun, Wollongong
2021-01-07
Active, closed
Daiichi Sankyo
Phase 3
605
Bedford Park, Blacktown, Heidelberg, North Ryde, Sydney, Wollongong
2020-12-21
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Ballarat, Bedford Park, Clayton, Garran, Hyde Park, Port Macquarie, Wollongong, Woolloongabba
2020-12-02
Active, closed
Bayer
Phase 4
654
Castle Hill, Gosford, Kingswood, North Tamworth, St Leonards, Sydney, Wollongong, Brisbane
2020-11-09
Active, closed
Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma
NCT04291885Merkel Cell Carcinoma, Merkel Cell Carcinoma, Stage I, Merkel Cell Carcinoma, Stage II, Merkel Cell Carcinoma, Stage III
DrugAvelumab
Melanoma and Skin Cancer Trials Limited
Phase 2
122
Port Macquarie, Sydney, Wollongong, Brisbane, Bundaberg, Cairns, Hervey Bay, Mackay
2020-10-26
Active, closed
Exelixis
Phase 3
575
Garran, Port Macquarie, Saint Leonards, Sydney, Wollongong, Chermside, Launceston, Ballarat
2020-10-19
Active, closed
Nyxoah S.A.
Not applicable
115
Wollongong, Heidelberg, Nedlands
2020-10-14
Active, closed
Janssen Research & Development, LLC
Phase 3
1,074
Bedford Park, Heidelberg, Malvern, Murdoch, Nedlands, Westmead, Wollongong, Woolloongabba
2020-09-30
Active, closed
AbbVie
Phase 3
527
Wollongong, South Brisbane, Southport, Elizabeth Vale, Clayton
2020-09-30
Active, closed
Sanofi
Phase 3
337
Liverpool, Waratah, Wollongong, Fitzroy, Heidelberg West, Richmond, Nedlands
2020-06-16
Active, closed
GlaxoSmithKline
Phase 3
494
Liverpool, Wollongong, Benowa
2020-05-07
Active, closed
University of Sydney
Phase 3
1,100
Albury, Gosford, Newcastle, Nowra, Sydney, Wollongong, Brisbane, Herston
2020-03-31
Recruiting
University of Leicester
Not applicable
2,104
Garran, Liverpool, St Leonards, Westmead, Wollongong, Chermside, Douglas, Southport
2020-03-10
By invitation
The TEAM Long-Term Cohort Study (A Sub-study of TEAM(III))
NCT05298982Critically Ill, Mechanical Ventilation, Long Term Outcome
Australian and New Zealand Intensive Care Research Centre
Observational
250
Camperdown, Sydney, Wollongong, Birtinya, Brisbane, Caboolture, Redcliffe, Toowoomba
2020-02-11
Active, closed
Hoffmann-La Roche
Phase 2/3
325
Macquarie Park, Wollongong, South Brisbane, Woolloongabba, Fitzroy, Frankston
2020-01-29
Recruiting
The University of Queensland
Not applicable
3,600
Camperdown, Kingswood, Kogarah, Saint Leonards, Westmead, Wollongong, Birtinya, Brisbane
2019-12-10
Active, closed
Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer
NCT04050436Cutaneous Squamous Cell Carcinoma, Advanced Cutaneous Squamous Cell Carcinoma, Metastatic Cutaneous Squamous Cell Carcinoma
DrugsVusolimogene Oderparepvec·Cemiplimab
Replimune, Inc.
Phase 2
231
Camperdown, Wollongong, Southport, Clayton, Melbourne, Nedlands
2019-10-08
Active, closed
Aspirin in Reducing Events in the Elderly-Extension (ASPREE-XT)
NCT07224347Functional Disability, Dementia, Heart Disease, Stroke
Anne Murray
Observational
19,114
Garran, Wollongong, Adelaide, Mount Gambier, Burnie, Hobart, Launceston, Bendigo
2019-07-15
Active, closed
Dizal Pharmaceuticals
Phase 1/2
315
Blacktown, Camperdown, Heidelberg, Kogarah, North Melbourne, Perth, Wollongong
2019-07-09
Active, closed
Institut de Recherches Internationales Servier
Phase 3
856
Blacktown, Frankston, Gateshead, Kogarah, Wahroonga, Wollongong
2019-03-21
Active, closed
A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer
NCT03816163Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma
DrugsZolbetuximab·Nab-paclitaxel·Gemcitabine
Astellas Pharma Global Development, Inc.
Phase 2
393
Gosford, Wollongong, Fitzroy, Warrnambool
2019-03-15
Active, closed
Celgene
Phase 3
363
Albury, Blacktown, Concord, Kogarah, Nowra, Waratah, Wollongong, Auchenflower
2019-01-02
Active, closed
AbbVie
Phase 3
265
Liverpool, Wahroonga, Wollongong, Hyde Park, South Brisbane, Woodville South, Nedlands
2018-10-22
Active, closed
AstraZeneca
Phase 3
1,018
Auchenflower, Box Hill, Brisbane, Kogarah, Orange, Parkville, Westmead, Wollongong
2018-05-14
Active, closed
University of Sydney
Phase 2
103
Campbelltown, Camperdown, Gosford, New Lambton Heights, Port Macquarie, Randwick, Saint Leonards, Wollongong
2018-02-22
Active, closed
Sanofi
Phase 3
475
Liverpool, Waratah, Wollongong, South Brisbane, Clayton, Heidelberg West, Nedlands, West Perth
2017-12-07
Active, closed
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers
NCT03212404Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Small Cell, Malignant Mesothelioma, Advanced
Checkpoint Therapeutics, Inc.
Phase 1
272
Wollongong, Benowa, Buderim, Greenslopes, South Brisbane, Woolloongabba, Box Hill, Malvern
2017-09-20
Active, closed
Eli Lilly and Company
Phase 3
5,637
Camperdown, Darlinghurst, Lismore, Liverpool, Sydney, Waratah, Westmead, Wollongong
2017-07-12
Active, closed
Alliance Foundation Trials, LLC.
Phase 3
5,796
Bowral, Coffs Harbour, Gateshead, Gosford, Macquarie Park, Orange, Wollongong, Brisbane
2015-08
Active, closed
Acerta Pharma BV
Phase 3
533
Darlinghurst, Frankston, Melbourne, St Leonards, Waratah NSW, Wollongong
2015-07-28
Active, closed
Acerta Pharma BV
Phase 3
535
Darlinghurst, Frankston, Geelong, South Brisbane, Waratah NSW, Wollongong, Woodville
2015-06-26
Recruiting
Western Sydney Local Health District
Not applicable
1,058
Garran, Kingswood, New Lambton Heights, Randwick, Saint Leonards, Westmead, Wollongong, Birtinya
2014-02-27
Active, closed
Australasian Gastro-Intestinal Trials Group
Phase 2/3
574
Newcastle, Sydney, Tweed Heads, Wollongong, Brisbane, Adelaide, Hobart, Launceston
2009-09
Rows per page Showing 1–148 of 148
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 October 2026. https://priyalifescience.com/clinical-trials-australia/city/wollongong

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,343 studies in total at the last sync on 15 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 148 of those studies with a site in Wollongong.

How many clinical trials are recruiting in Wollongong?

75 of the 148 studies on this page are recruiting new participants as of the 15 Oct 2026, 03:18 UTC sync. A further 5 have not yet opened recruitment, 66 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Wollongong), 148 studies
PhaseStudiesRecruitingShare
Phase 3611941.2%
Phase 2261517.6%
Phase 1/2241816.2%
Phase 114109.5%
Not applicable1197.4%
Phase 2/3724.7%
Early Phase 1221.4%
Observational201.4%
Phase 4100.7%

Most active sponsors

Lead sponsors with the most studies (Wollongong)
Lead sponsorStudiesRecruiting
AstraZeneca1410
Sanofi72
Janssen Research & Development, LLC63
AbbVie51
Amgen41
Australasian Gastro-Intestinal Trials Group42
Novo Nordisk A/S40
Regeneron Pharmaceuticals42
BioNTech SE32
Daiichi Sankyo31
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.